Clinical Trial: Application of KRAS Vaccine in the Treatment of KRAS-mutated Malignancies

U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07004244) titled 'Application of KRAS Vaccine in the Treatment of KRAS-mutated Malignancies' on May 26.

Brief Summary: The goal of this study is to evaluate the safety and efficacy of mRNA vaccine for the KRAS mutation malignant tumors.

Study Start Date: May 26

Study Type: INTERVENTIONAL

Condition: Malignant Tumors

Intervention: BIOLOGICAL: KRAS-mutated mRNA vaccine

From the initial dose, the dose was increased using a dose escalation scheme. Each subject only received one corresponding dose.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Sichuan University

Information provided by (Responsible Party): Zhen-Yu Ding, Sichuan University

Publi...